A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

Starting soon

Conditions studied: Glioblastoma Multiforme

In brief

Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in glioblastoma multiforme clinical study, as well as the reasons for withdrawal or discontinuation. Insights gained from this study will ultimately benefit those with glioblastoma multiforme who may be invited to participate in clinical trial in the years to come.

Key facts

Study ID

NCT05958485

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-08-01

Expected to finish

2026-08-01

Last updated by the study team

2023-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of glioblastoma multiforme
• No prior treatment for glioblastoma multiforme
• Ability to understand and the willingness to sign a written informed consent document.

You may not qualify if…

• Female patients who are currently pregnant or nursing
• Enrolled in another research study
• Patients who are currently receiving any other investigational drug.

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.